Correlation between Highly Sensitive C Reactive Protein and Development of Microvascular Complications of Type 2 Diabetes Mellitus | ||||
Egyptian Journal of Medical Microbiology | ||||
Article 10, Volume 31, Issue 1, January 2022, Page 69-73 PDF (314.51 K) | ||||
Document Type: New and original researches in the field of Microbiology. | ||||
DOI: 10.21608/ejmm.2022.211968 | ||||
View on SCiNiTO | ||||
Authors | ||||
Amal Hassaan1; Mohamed I. Abd El-Ghany2; Waleed Eldars 3; Talat A. Othman1 | ||||
1Medical Microbiology and Immunology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt | ||||
2Department of Internal medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt | ||||
3Department of Medical Microbiology and Immunology, Faculty of Medicine, Mansoura University, Mansoura, Egypt. | ||||
Abstract | ||||
Background: Microvascular problems associated with type 2 diabetes mellitus (T2DM) are a leading source of morbidity and mortality in T2DM patients, thus the search for new biomarkers to identify and treat those at high risk is intensifying. Objective: This controlled cross-sectional study aimed to investigate whether there is a correlation between serum levels of highly sensitive C reactive protein (hsCRP) and development of microvascular complications in T2DM.Methodology: Hundred and thirty-five subjects aged from 35 to 70 years were subdivided into 3 groups. Detailed clinical history was taken. Serum levels of hsCRP were estimated using Immune Turbidimetry. Results: Serum hsCRP levels were higher in group A than other studied groups. However, there was no statistically significant difference between group A and B(P=0.35). Serum hsCRP levels were significantly higher in patients with diabetic nephropathy than patients without nephropathy (P=0.016). The difference between serum hsCRP levels in patients with and without retinopathy and neuropathy was not significant (P=0.39 and P=0.53 respectively). Conclusion: Serum hsCRP can be used as a novel marker for diagnosis of microvascular complications in T2DM patients. Abbreviations: (T2DM: Type 2 Diabetes Mellitus, hsCRP: highly sensitive C Reactive Protein, eGFR: Estimated Glomerular filteration Rate, BUN: Blood Urea Nitrogen, HbA1c: Glycosylated Hemoglobin). | ||||
Keywords | ||||
T2DM; microvascular complications; hsCRP | ||||
Statistics Article View: 244 PDF Download: 221 |
||||